Skip to main content
    N

    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.54
    -0.37 (-7.54%)

    Market Cap: $141.66M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    NeOnc Technologies Holdings, Inc. Common Stock reported revenue of $39.99K for the fiscal year ended Dec 31, 2025, down 51.8% from the year before. That year, net income was -$62.15M with a net margin of -155404.4%, operating cash flow was -$20.36M and free cash flow was -$20.86M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$4.44M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$39.99K-51.8%100.0%-145637.5%-155404.4%
    Dec 2024$83.00K+17.8%100.0%-8605.4%-14335.5%
    Dec 2023$70.46K+252.3%100.0%-17311.0%-21176.0%
    Dec 2022$20.00KN/A100.0%-14188.0%-15233.8%
    Dec 2021$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2021 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Revenue$39.99K$83.00K$70.46K$20.00K$0
    Cost of revenue$0$0$2.74MN/AN/A
    Gross profit$39.99K$83.00K$70.46K$20.00KN/A
    Research and development$3.64M$3.05M$1.53M$1.16M$674.56K
    Operating income-$58.24M-$7.14M-$12.20M-$2.84M-$3.27M
    Net income-$62.15M-$11.90M-$14.92M-$3.05M-$3.38M
    EBITDAN/A-$6.90M-$12.20MN/A-$3.26M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$39.99K$20.00K$0$20.00K$43.00K$0
    Gross profit$0$0$0N/A$0$0$39.99K$20.00K$0$20.00K$43.00KN/A
    Operating income-$5.83M-$14.07M-$7.06M-$8.02M-$6.93M-$5.71M-$31.90M-$2.11M-$2.20M-$1.28M-$1.55M-$4.81M
    Net income-$4.44M-$14.24M-$8.82M-$9.85M-$8.62M-$5.68M-$32.33M-$2.25M-$2.18M-$4.52M-$2.94M-$6.16M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, short-term debt of $5.95M exceeded cash and equivalents by $5.89M. Shareholder equity was negative, at -$17.51M, as total liabilities of $20.33M exceeded total assets of $2.82M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Total assets$2.82M$3.42M$1.27M$728.68K$32.49K
    Current assets$1.39M$2.20M$1.27M$728.68K$32.49K
    Cash and equivalents$58.73K$64.89K$31.86K$633.30K$25.03K
    Total liabilities$20.33M$8.92M$15.25M$2.30M$2.65M
    Short-term debt$5.95M$0$6.61M$50.00K$1.15M
    Shareholder equity-$17.51M-$5.50M-$13.99M-$1.58M-$2.62M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$9.30M$5.23M$3.33M$2.82M$4.08M$2.99M$8.44M$3.42M$2.74MN/AN/A$1.27M
    Total liabilities$22.48M$23.76M$16.56M$20.33M$15.90M$14.80M$18.07M$8.92M$8.01MN/A$13.99M$15.25M
    Cash and equivalents$6.17M$1.97M$138.60K$58.73K$1.51M$125.04K$5.44M$64.89K$1.33MN/AN/A$31.86K
    Shareholder equity-$13.17M-$18.53M-$13.23M-$17.51M-$11.81M-$11.82M-$9.62M-$5.50M-$5.27MN/A-$13.99M-$13.99M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Operating cash flow-$20.36M-$4.21M-$1.88M-$881.74K-$396.69K
    Capital expenditures$500.00K$0$0$4$3
    Free cash flow-$20.86M-$4.21M-$1.88M-$881.74K-$396.70K
    Investing cash flow-$500.00K$0N/AN/AN/A
    Financing cash flow$20.86M$4.25M$1.28M$1.49M$250.00K
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$5.09M-$4.77M-$6.99M-$3.59M-$5.81M-$5.31M-$5.65M-$954.40K-$3.09M-$318.20K$145.75K-$371.87K
    Capital expendituresN/AN/A$3$0$5$0$5$4$0$0$3$4
    Free cash flowN/AN/A-$6.99M-$3.59M-$5.81M-$5.31M-$5.65M-$954.41K-$3.09M-$318.20K$145.74K-$371.87K
    Last 12 quarters

    Frequently Asked Questions About NTHI

    What is NeOnc Technologies Holdings, Inc. Common Stock's annual revenue?

    NeOnc Technologies Holdings, Inc. Common Stock reported revenue of $39.99K for the fiscal year ended Dec 31, 2025.

    How fast is NeOnc Technologies Holdings, Inc. Common Stock's revenue growing?

    Revenue was down 51.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 26.0%.

    Is NeOnc Technologies Holdings, Inc. Common Stock profitable?

    No. NeOnc Technologies Holdings, Inc. Common Stock reported net income of -$62.15M for the fiscal year ended Dec 31, 2025, with a net margin of -155404.4%.

    How much free cash flow does NTHI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$20.36M minus capital expenditures of $500.00K produced free cash flow of -$20.86M.

    How much debt does NeOnc Technologies Holdings, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $5.95M and cash and equivalents of $58.73K.